Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...
Main Authors: | Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BioMed Central
2016
|
Registos relacionados
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomized controlled trial
Por: Saunders, K, et al.
Publicado em: (2016) -
Older patients are eligible for trial of lithium and valproate.
Por: Rendell, J, et al.
Publicado em: (2003) -
New trial should clarify lithium use in bipolar disorder.
Por: Geddes, J, et al.
Publicado em: (2002) -
Lith6
Por: Malcolm A. Lyons, et al.
Publicado em: (2003-09-01) -
The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
Por: Atkinson, L, et al.
Publicado em: (2019)